BG105340A - Carbamate and urea compositions and neurotrophic uses - Google Patents
Carbamate and urea compositions and neurotrophic usesInfo
- Publication number
- BG105340A BG105340A BG105340A BG10534001A BG105340A BG 105340 A BG105340 A BG 105340A BG 105340 A BG105340 A BG 105340A BG 10534001 A BG10534001 A BG 10534001A BG 105340 A BG105340 A BG 105340A
- Authority
- BG
- Bulgaria
- Prior art keywords
- neurotrophic
- carbamate
- urea compositions
- compositions
- urea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/139,672 US6242468B1 (en) | 1997-02-27 | 1998-08-25 | Carbamate and urea compositions and neurotrophic uses |
PCT/US1999/019261 WO2000010553A2 (en) | 1998-08-25 | 1999-08-24 | Carbamate and urea compositions and neurotrophic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105340A true BG105340A (en) | 2001-12-29 |
Family
ID=22487769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105340A BG105340A (en) | 1998-08-25 | 2001-03-14 | Carbamate and urea compositions and neurotrophic uses |
Country Status (18)
Country | Link |
---|---|
US (1) | US6242468B1 (pt) |
EP (1) | EP1107757A2 (pt) |
JP (1) | JP2002523367A (pt) |
KR (1) | KR20010072992A (pt) |
CN (1) | CN1313767A (pt) |
AU (1) | AU5687999A (pt) |
BG (1) | BG105340A (pt) |
BR (1) | BR9912988A (pt) |
CA (1) | CA2341530A1 (pt) |
CZ (1) | CZ2001274A3 (pt) |
EA (1) | EA200100271A1 (pt) |
HU (1) | HUP0103166A3 (pt) |
IL (1) | IL140958A0 (pt) |
MX (1) | MXPA01001937A (pt) |
NO (1) | NO20010946L (pt) |
PL (1) | PL346759A1 (pt) |
SK (1) | SK2562001A3 (pt) |
WO (1) | WO2000010553A2 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008960B1 (en) | 1999-03-02 | 2006-03-07 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
EP1196386A2 (en) * | 1999-07-06 | 2002-04-17 | Vertex Pharmaceuticals Incorporated | N-substituted glycine derivatives |
US7977385B2 (en) * | 2000-03-02 | 2011-07-12 | Numoda Biotechnologies, Inc. | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
US20030199574A1 (en) * | 2000-03-02 | 2003-10-23 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
US20050137124A1 (en) * | 2002-08-09 | 2005-06-23 | Vitreo-Retinal Technologies, Inc. A California Corporation | Agents for intravitreal administration to treat or prevent disorders of the eye |
EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
AU2005219822A1 (en) | 2004-03-02 | 2005-09-15 | Wyeth | Macrolides and methods for producing same |
US20050197356A1 (en) * | 2004-03-02 | 2005-09-08 | Wyeth | Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
WO2007061554A2 (en) * | 2005-10-21 | 2007-05-31 | Purdue Research Foundation | Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries |
JP2015504054A (ja) * | 2011-12-27 | 2015-02-05 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 多発性硬化症の治療または予防に使用されるフェニルカルバメート化合物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI874163A (fi) | 1986-09-26 | 1988-03-27 | Mitsui Toatsu Chemicals | Katekolderivat samt preparat innehaollande desamma foer haemmande och botande av regressiva sjukdomar i det centrala nervsystemet. |
US5214034A (en) | 1986-09-26 | 1993-05-25 | Mitsui Toatsu Chemicals, Incorporated | Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same |
IT1206078B (it) | 1987-06-03 | 1989-04-14 | Polifarma Spa | Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico |
US5232923A (en) | 1988-03-18 | 1993-08-03 | Mitsui Toatsu Chemicals, Incorporated | Catechol derivatives and pharmaceutical preparations containing same |
US5166317A (en) | 1988-10-31 | 1992-11-24 | Houston Biotechnology Incorporated | Neurotrophic factor |
US5215969A (en) | 1989-08-11 | 1993-06-01 | Hahnemann University | Dopaminergic neurotrophic factor for treatment of Parkinson's disease |
US5620971A (en) | 1991-05-09 | 1997-04-15 | Vertex Pharmaceuticals Incorporated | Biologically active acylated amino acid derivatives |
US5744485A (en) | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
IL115685A (en) * | 1994-11-16 | 2000-08-31 | Vertex Pharma | Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
US6037370A (en) | 1995-06-08 | 2000-03-14 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5717092A (en) | 1996-03-29 | 1998-02-10 | Vertex Pharmaceuticals Inc. | Compounds with improved multi-drug resistance activity |
US5811434A (en) | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
US5840736A (en) | 1996-11-13 | 1998-11-24 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5780484A (en) | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
US5935989A (en) * | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
ZA98825B (en) * | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
-
1998
- 1998-08-25 US US09/139,672 patent/US6242468B1/en not_active Expired - Fee Related
-
1999
- 1999-08-24 EP EP99943869A patent/EP1107757A2/en not_active Withdrawn
- 1999-08-24 SK SK256-2001A patent/SK2562001A3/sk unknown
- 1999-08-24 HU HU0103166A patent/HUP0103166A3/hu unknown
- 1999-08-24 EA EA200100271A patent/EA200100271A1/ru unknown
- 1999-08-24 IL IL14095899A patent/IL140958A0/xx unknown
- 1999-08-24 PL PL99346759A patent/PL346759A1/xx unknown
- 1999-08-24 BR BR9912988-4A patent/BR9912988A/pt not_active IP Right Cessation
- 1999-08-24 JP JP2000565875A patent/JP2002523367A/ja active Pending
- 1999-08-24 MX MXPA01001937A patent/MXPA01001937A/es not_active IP Right Cessation
- 1999-08-24 KR KR1020017002444A patent/KR20010072992A/ko not_active Application Discontinuation
- 1999-08-24 CN CN99810011A patent/CN1313767A/zh active Pending
- 1999-08-24 CA CA002341530A patent/CA2341530A1/en not_active Abandoned
- 1999-08-24 CZ CZ2001274A patent/CZ2001274A3/cs unknown
- 1999-08-24 WO PCT/US1999/019261 patent/WO2000010553A2/en not_active Application Discontinuation
- 1999-08-24 AU AU56879/99A patent/AU5687999A/en not_active Abandoned
-
2001
- 2001-02-23 NO NO20010946A patent/NO20010946L/no not_active Application Discontinuation
- 2001-03-14 BG BG105340A patent/BG105340A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR9912988A (pt) | 2001-10-02 |
US6242468B1 (en) | 2001-06-05 |
NO20010946D0 (no) | 2001-02-23 |
AU5687999A (en) | 2000-03-14 |
CZ2001274A3 (cs) | 2001-09-12 |
SK2562001A3 (en) | 2001-09-11 |
PL346759A1 (en) | 2002-02-25 |
KR20010072992A (ko) | 2001-07-31 |
WO2000010553A2 (en) | 2000-03-02 |
JP2002523367A (ja) | 2002-07-30 |
WO2000010553A3 (en) | 2000-05-18 |
EA200100271A1 (ru) | 2001-10-22 |
MXPA01001937A (es) | 2002-04-24 |
CN1313767A (zh) | 2001-09-19 |
NO20010946L (no) | 2001-02-23 |
CA2341530A1 (en) | 2000-03-02 |
IL140958A0 (en) | 2002-02-10 |
HUP0103166A3 (en) | 2002-10-28 |
HUP0103166A2 (hu) | 2002-05-29 |
EP1107757A2 (en) | 2001-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69730157D1 (de) | Molekül, welches genotyp und phänotyp zusammenführt und dessen anwendungen | |
CA2248110A1 (en) | (hydroxyalkyl)urea crosslinking agents | |
DK1091975T3 (da) | Ny cyclosporin med forbedret aktivitetsprofil | |
EP0960107A4 (pt) | ||
ID23374A (id) | Halogenopirimidin | |
MA24643A1 (fr) | Tetrahydro-naphtalenes substitues et composes analogues | |
HK1054746A1 (en) | Hexahydrofuro'2,3-B!furan-3-yl-N- Ä3'(1,3-benzodioxol -5- ylsulfonyl) (isobutyl) amino! -1-benzyl-2-hydroxypropylÜ carbamate as retroviral protease inhibitor. | |
IL109901A (en) | Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them | |
DE59003133D1 (de) | Lenkrolle für verfahrbare Arbeitsbühnen, Gerüste od.dgl. | |
MA26846A1 (fr) | Derives de 2,4-diaminopyrimidine utiles comme agents immunosuppresseurs. | |
BG105340A (en) | Carbamate and urea compositions and neurotrophic uses | |
HUP0102671A3 (en) | Immunosupressive pharmaceutical compositions containing 2',2'-difluoro-nucleoside analogues | |
WO2002067865A3 (en) | N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof | |
CA2327784A1 (en) | Triazolones with a neuroprotective action | |
DE69816059D1 (de) | Gen, das für das pyruvat dehydrogenase kinase von pflanzen kodiert | |
WO1998027058A3 (en) | N-piperazin-1-ylphenyl-benzamide derivatives | |
WO2001009122A3 (en) | Serotonergic benzofurans | |
WO1999037291A3 (de) | Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe | |
CA2205868A1 (en) | Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them | |
WO1999043285A3 (en) | Sulphonamide derivatives | |
ATE219665T1 (de) | Dosisformen und deren verwendungen | |
ZA200104304B (en) | Carbamate derivatives of diaryl 1,3,4-oxadiazolone. | |
DE69818492D1 (en) | 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele | |
ATE234816T1 (de) | Von azacycloalkanen abgeleitete urethane, ihre thio- und dithioanaloga, deren herstellung und deren verwendung als 2,3-epoxisqualen-lanosterol- cyclase inhibitoren | |
MXPA04005226A (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion. |